Pair Name | Curcumin, Anti-PD-1 antibody | ||
Phytochemical Name | Curcumin (PubChem CID: 969516 ) | ||
Anticancer drug Name | Anti-PD-1 antibody (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Curcumin, Anti-PD-1 antibody | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Induction-->Immune evasion | |||
Gene Regulation | Down-regulation | Expression | EP300 | hsa2033 |
Down-regulation | Activity | SMAD2/3 | KEGG ID N.A. | |
Down-regulation | Expression | TGFB1 | hsa7040 | |
In Vitro Model | Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens (Human) | CVCL_0326 |
In Vivo Model | Hep3B cells in the logarithmic growth phase were suspended in 50% Matrigel (BD Biosciences) and adjusted to a density of 2×10⁶ cells/mL, and 0.2 mL of single-cell suspension was subcutaneously injected into the left axilla of each mouse. | |||
Result | Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma |
No. | Title | Href |
---|---|---|
1 | Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma. Life Sci. 2021 Aug 15;279:119359. doi: 10.1016/j.lfs.2021.119359. | Click |